fashion -WSS

fashion

author：explore 2025-10-02 18:06:16 - browse：765

Sens. Ron Wyden and Mike Crapo introduced a mental health, PBM reform and substance use policy package. Drew Angerer/Getty Images

WASHINGTON — A key Senate panel announced it will consider more policies to regulate pharmacy middlemen and ensure patients aren’t paying more than insurers do for medications.

The package crafted by Senate Finance Chair Ron Wyden (D-Ore.) and Mike Crapo (R-Idaho) is slated to be marked up on Nov. 8, and includes policy on a broad range of health care priorities, including substance abuse and mental health care, and extensions to provider pay. The pharmacy benefit manager regulations build on a separate package of PBM regulations that the panel passed in July.

The most impactful proposal would allow the Department of Health and Human Services to designate a list of so-called discounted drugs. Medicare beneficiaries taking those drugs would see their share of the cost based on the net price, rather than the list price, under the new proposal.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Bernie Sanders gets little from pharma CEOs on drug prices

focus

WSS

Too many hospitalized Covid

Listen: Racing for gene therapy & a pioneering approval

Congress must give Medicare recipients genetic counseling access

Beware the threat of staffing cuts at the CDC

Cancer drug shortages' outsize impact on ovarian cancer patients

The pain doctors face in trying to build their families

focus

fashion

focus

In age of alternative facts, a scholarly course on calling out crap

Trump's false claims about Georgia's 2020 election long debunked

After affirmative action ruling, medical educators look to 'holistic review'

Eye stem cell transplant could help restore vision in injured people

As demand for Covid shots wanes, Moderna seeks its next success

Congress must give Medicare recipients genetic counseling access

FDA approval of Sarepta Duchenne genetic therapy gives me hope

New definition of a human embryo proposed amid rapid advances

The high cost of giving birth even with insurance

Report cites 'urgent' need to recruit more diverse clinical trial participants

entertainment

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Eye stem cell transplant could help restore vision in injured people

Juul documents reveal insider tactics on political lobbying

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Bernie Sanders gets little from pharma CEOs on drug prices

Beware the threat of staffing cuts at the CDC

Wikipedia

focus

explore

hotspot